ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,687Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 68

$782K Total Retail Price of All Prescriptions

Rank: 8 out of 68

438 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 438 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

14% of this provider’s 438 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 14,095 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 744 730 1 8
SIMVASTATIN 615 574 2 1
FUROSEMIDE 532 525 3 3
LISINOPRIL 520 485 4 4
METOPROLOL TARTRATE 520 510 4 6
LEVOTHYROXINE SODIUM 460 459 6 2
HYDROCHLOROTHIAZIDE 457 444 7 11
POTASSIUM CHLORIDE 454 449 8 18
AMLODIPINE BESYLATE 441 424 9 7
DONEPEZIL HCL 439 439 10 10
ATORVASTATIN CALCIUM 383 362 11 13
OMEPRAZOLE 367 361 12 5
METFORMIN HCL 309 298 13 14
NAMENDA 297 297 14 16
HYDROCODONE-ACETAMINOPHEN 263 249 S3 15 17
ATENOLOL 259 226 16 21
ALENDRONATE SODIUM 226 217 17 26
DIGOXIN 198 197 18 45
PANTOPRAZOLE SODIUM 197 188 19 30
GLYBURIDE 180 176 R 20 65
CITALOPRAM HBR 151 134 21 9
JANUVIA 139 133 22 96
ISOSORBIDE MONONITRATE ER 128 127 23 35
FENTANYL 109 98 S2 24 39
SERTRALINE HCL 107 105 25 20
OXYCODONE-ACETAMINOPHEN 105 91 S2 26 43
CLOPIDOGREL 105 100 26 31
LOSARTAN POTASSIUM 104 99 28 37
GABAPENTIN 97 96 29 12
METOPROLOL SUCCINATE 94 94 30 19
QUINAPRIL HCL 94 94 30 109
LANTUS 93 86 32 36
PRAVASTATIN SODIUM 91 75 33 29
TRAZODONE HCL 88 88 34 32
AMLODIPINE BESYLATE-BENAZEPRIL 87 87 35 179
RANITIDINE HCL 87 87 35 34
LACTULOSE 83 82 37 127
TAMSULOSIN HCL 83 76 37 28
EVISTA 83 83 37 211
BENAZEPRIL HCL 80 74 40 119
ACETAMINOPHEN-CODEINE 78 65 S3 41 73
TRAMADOL HCL 77 74 42 23
FINASTERIDE 76 69 43 70
MIRTAZAPINE 75 75 44 15
ZOLPIDEM TARTRATE 75 73 44 53
PLAVIX 75 74 44 48
NEXIUM 74 69 47 62
PRANDIN 73 69 48 107
ENALAPRIL MALEATE 70 67 49 61
CLONIDINE HCL 65 65 50 94
ZETIA 63 56 51 110
OXYBUTYNIN CHLORIDE 62 53 52 89
SYNTHROID 61 60 53 102
FLUTICASONE PROPIONATE 60 59 54 66
ALLOPURINOL 59 52 55 46
VERAPAMIL ER 57 57 56 142
POLYETHYLENE GLYCOL 3350 55 55 57 22
METFORMIN HCL ER 55 48 57 163
ROPINIROLE HCL 55 55 57 119
ACTONEL 53 53 60 199
SPIRIVA 52 52 61 60
PROPRANOLOL HCL 52 42 61 172
HUMALOG 51 50 63 72
VESICARE 51 47 63 149
DIOVAN 50 39 65 42
LIPITOR 50 46 65 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.